Cargando…

Commercialization, Diffusion and Adoption of Bioformulations for Sustainable Disease Management in Indian Arid Agriculture: Prospects and Challenges

Trichoderma spp. is one of the most popular genus of fungi commercially available as a plant growth promoting fungus (PGPF) and biological control agent. More than 80 species of Trichoderma are reported in the literature. However T. asperellum, T. harzianum, T. viride, and T. virens are most commonl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mawar, Ritu, Manjunatha, B. L., Kumar, Sanjeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272838/
https://www.ncbi.nlm.nih.gov/pubmed/34888568
http://dx.doi.org/10.1007/s43615-021-00089-y
_version_ 1783721275138506752
author Mawar, Ritu
Manjunatha, B. L.
Kumar, Sanjeev
author_facet Mawar, Ritu
Manjunatha, B. L.
Kumar, Sanjeev
author_sort Mawar, Ritu
collection PubMed
description Trichoderma spp. is one of the most popular genus of fungi commercially available as a plant growth promoting fungus (PGPF) and biological control agent. More than 80 species of Trichoderma are reported in the literature. However T. asperellum, T. harzianum, T. viride, and T. virens are most commonly utilized as biocontrol agents. Studies were initiated to explore the potential of biocontrol agents in order to develop a cost effective and practical management strategy. Analysis of large number of soil samples collected from western parts of the region led to isolation of native biocontrol agents viz., Trichoderma harzianum, Aspergillus versicolor, and Bacillus firmus from different agricultural systems. These biocontrol agents have proved their antagonistic ability in laboratory tests and field trials. In India, two species of Trichoderma i.e., T. viride and T. harzianum are commercially registered for usage against soil borne plant pathogens mostly as a seed treatment or soil application. There are published scientific papers on the efficacy of T. asperellum and T. virens in India for suppressing pathogens but these are not yet registered under Central Insecticide Board and Registration Committee (CIB & RC). This review article focuses on the uses, commercialization and adoption issues of various fungal and bacterial consortium products in sustainable disease management.
format Online
Article
Text
id pubmed-8272838
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82728382021-07-12 Commercialization, Diffusion and Adoption of Bioformulations for Sustainable Disease Management in Indian Arid Agriculture: Prospects and Challenges Mawar, Ritu Manjunatha, B. L. Kumar, Sanjeev Circ Econ Sustain Original Paper Trichoderma spp. is one of the most popular genus of fungi commercially available as a plant growth promoting fungus (PGPF) and biological control agent. More than 80 species of Trichoderma are reported in the literature. However T. asperellum, T. harzianum, T. viride, and T. virens are most commonly utilized as biocontrol agents. Studies were initiated to explore the potential of biocontrol agents in order to develop a cost effective and practical management strategy. Analysis of large number of soil samples collected from western parts of the region led to isolation of native biocontrol agents viz., Trichoderma harzianum, Aspergillus versicolor, and Bacillus firmus from different agricultural systems. These biocontrol agents have proved their antagonistic ability in laboratory tests and field trials. In India, two species of Trichoderma i.e., T. viride and T. harzianum are commercially registered for usage against soil borne plant pathogens mostly as a seed treatment or soil application. There are published scientific papers on the efficacy of T. asperellum and T. virens in India for suppressing pathogens but these are not yet registered under Central Insecticide Board and Registration Committee (CIB & RC). This review article focuses on the uses, commercialization and adoption issues of various fungal and bacterial consortium products in sustainable disease management. Springer International Publishing 2021-07-11 2021 /pmc/articles/PMC8272838/ /pubmed/34888568 http://dx.doi.org/10.1007/s43615-021-00089-y Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Paper
Mawar, Ritu
Manjunatha, B. L.
Kumar, Sanjeev
Commercialization, Diffusion and Adoption of Bioformulations for Sustainable Disease Management in Indian Arid Agriculture: Prospects and Challenges
title Commercialization, Diffusion and Adoption of Bioformulations for Sustainable Disease Management in Indian Arid Agriculture: Prospects and Challenges
title_full Commercialization, Diffusion and Adoption of Bioformulations for Sustainable Disease Management in Indian Arid Agriculture: Prospects and Challenges
title_fullStr Commercialization, Diffusion and Adoption of Bioformulations for Sustainable Disease Management in Indian Arid Agriculture: Prospects and Challenges
title_full_unstemmed Commercialization, Diffusion and Adoption of Bioformulations for Sustainable Disease Management in Indian Arid Agriculture: Prospects and Challenges
title_short Commercialization, Diffusion and Adoption of Bioformulations for Sustainable Disease Management in Indian Arid Agriculture: Prospects and Challenges
title_sort commercialization, diffusion and adoption of bioformulations for sustainable disease management in indian arid agriculture: prospects and challenges
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272838/
https://www.ncbi.nlm.nih.gov/pubmed/34888568
http://dx.doi.org/10.1007/s43615-021-00089-y
work_keys_str_mv AT mawarritu commercializationdiffusionandadoptionofbioformulationsforsustainablediseasemanagementinindianaridagricultureprospectsandchallenges
AT manjunathabl commercializationdiffusionandadoptionofbioformulationsforsustainablediseasemanagementinindianaridagricultureprospectsandchallenges
AT kumarsanjeev commercializationdiffusionandadoptionofbioformulationsforsustainablediseasemanagementinindianaridagricultureprospectsandchallenges